ANTI-LEU-7 IMMUNOREACTIVITY WITH HUMAN-TUMORS - ITS VALUE IN THE DIAGNOSIS OF PROSTATIC ADENOCARCINOMA

被引：35

作者：

MAY, EE ^{[1
]}

PERENTES, E ^{[1
]}

机构：

[1] UNIV VIRGINIA,SCH MED,DEPT PATHOL,DIV NEUROPATHOL,CHARLOTTESVILLE,VA 22908

来源：

关键词：

D O I：

10.1111/j.1365-2559.1987.tb02634.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：295 / 304

页数：10

共 28 条

[1] ABO T, 1981, J IMMUNOL, V127, P1024
[2] IMMUNOHISTOCHEMICAL DEMONSTRATION OF PROSTATIC ORIGIN OF METASTASES
BENTZ, MS
COHEN, C
DEMERS, LM
BUDGEON, LR
[J]. UROLOGY, 1982, 19 (06) : 584 - 586
[3] BUNN PA, 1985, BLOOD, V65, P764
[4] BURNS J, 1977, BIOMED EXPRESS, V27, P7
[5] CAILLAUD JM, 1984, CANCER RES, V44, P4432
[6] COLE SPC, 1985, CANCER RES, V45, P4285
[7] MULTIPLE IMMUNOPEROXIDASE MARKERS IN BENIGN HYPERPLASIA AND ADENOCARCINOMA OF THE PROSTATE
ELLIS, DW
LEFFERS, S
DAVIES, JS
NG, ABP
[J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 81 (03) : 279 - 284
[8] FERRARINI M, 1983, J CLIN IMMUNOL, V3, P30, DOI 10.1007/BF00919136
[9] PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING
GLEASON, DF
MELLINGE.GT
[J]. JOURNAL OF UROLOGY, 1974, 111 (01) : 58 - 64
[10] JOBSIS AC, 1978, CANCER, V41, P1788, DOI 10.1002/1097-0142(197805)41:5<1788::AID-CNCR2820410521>3.0.CO